Why GLP-1 Developer Vivani Medical's Stock Is Climbing
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
Vivani Medical, Inc. (NASDAQ:VANI) shares are trading higher Thursday after the company announced the FDA cleared the Investigational New Drug application and lifted the clinical hold on NPM-119.
Vivani医疗公司（NASDAQ:VANI）股票周四上涨，此前该公司宣布FDA已批准其新药申报，并解除该公司NPM-119的临床暂停。
The Details:
细节：
The FDA's actions clear the way for the initiation of Vivani's LIBERATE-1 Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetics of NPM-119, the company's miniature, six-month GLP-1 implant in development for the treatment of type 2 diabetes.
FDA的行动为Vivani的LIBERATE-1第一期临床试验开展铺平了道路，旨在评估NPM-119(該公司正在研发的小型、持续六个月的GLP-1植入物)的安全性、耐受性和药代动力学，以治疗2型糖尿病。
"Today marks a significant milestone for Vivani as we transition to a clinical-stage company with a promising drug candidate that has the potential to address medication non-adherence, which affects approximately 50% of patients with type 2 diabetes. LIBERATE-1 represents our first-in-human study of NPM-119 in type 2 diabetes patients, as well as the first clinical application of our innovative NanoPortal implant technology in humans," said Adam Mendelsohn, Ph.D., Vivani's CEO.
“对于Vivani来说，今天是一个重要的里程碑，我们正在向临床阶段公司转型，拥有一个有希望的药物候选人，可以解决药物不依从性的问题，该问题影响50%左右的2型糖尿病患者。LIBERATE-1是我们在2型糖尿病患者中使用NPM-119的首例人体试验，也是我们创新的纳米门户植入技术在人类中的首次临床应用。”Vivani CEO Adam Mendelsohn博士说。
Vivani shares are moving on heavy trading volume following the company's announcement. According to data from Benzinga Pro, more than 11.7 million shares have already been traded in the session, compared to the stock's 100-day average of less than 174,000 shares.
Vivani股票的交易量较大，据Benzinga Pro数据显示，本次交易中已经交易了超过1170万股，相比股票100天的平均交易量不到174000股。
Related News: Virgin Galactic's Board Approves Reverse Stock Split: What's Going On With The Stock?
相关资讯：维珍银河董事会批准股票进行反向分割：股票有什么情况？
How To Buy VANI Stock:
如何购买VANI股票:
By now you're likely curious about how to participate in the market for Vivani Medical – be it to purchase shares, or even attempt to bet against the company.
现在你可能对如何参与Vivani医疗公司的市场感到好奇-不论是购买股票，还是尝试做空该公司。
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
购买股票通常是通过券商账户完成的。您可以在此处找到可能的交易平台列表。许多交易平台允许您购买'碎股'，这样可以让您拥有股票的一部分而不用购买整股。例如，某些股票，如伯克希尔哈撒韦公司，可能需要数千美元才能拥有一股。但是，如果您只想投资其中的一部分，券商将允许您这样做。
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
如果您想押注股票下跌，流程就更为复杂了。您需要访问期权交易平台，或者找一家券商让您通过借出股票进行“开空”操作（借股出售）。您可以在该资源中了解到卖空股票的过程。否则，如果您的券商允许您交易期权，您可以在当前股票交易价以上的执行价上购买看跌期权或者卖出看涨期权 - 无论哪种情况都可以让您从股票价格下跌中获利。
VANI Price Action: According to Benzinga Pro, Vivani Medical shares are up 3% at $1.68 at the time of publication Thursday.
Vivani医疗公司股票据Benzinga Pro报道，本次发布时上涨3%，股价为1.68美元。
Image: Mohamed Hassan from Pixabay
图片：来自Pixabay的Mohamed Hassan